Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Traws Pharma Inc (TRAW)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Traws Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.661 +0.020    +3.06%
21:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.668
+0.007
+1.044%
21:23:24 - Real-time Data
  • Volume: 17,443
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.640 - 0.669
Type:  Equity
Market:  United States
Traws Pharma 0.661 +0.020 +3.06%

TRAW Balance Sheet

 
Assess the latest Traws Pharma Inc balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced TRAW Annual Report data, financial summaries and charts are available for Traws Pharma Inc investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 22.66 27.01 30.45 35.04
Cash and Short Term Investments 20.82 25.24 29.73 34.22
Cash - - - -
Cash & Equivalents 20.82 25.24 29.73 34.22
Short Term Investments - - - -
Total Receivables, Net 0.018 0.018 0.017 0.017
Accounts Receivables - Trade, Net 0.018 0.018 0.017 0.017
Total Inventory 0.186 0.213 0.098 0.084
Prepaid Expenses 0.174 0.135 0.062 0.188
Other Current Assets, Total 1.46 1.4 0.544 0.53
Total Assets 22.68 27.04 30.47 35.06
Property/Plant/Equipment, Total - Net 0.022 0.026 0.017 0.021
Property/Plant/Equipment, Total - Gross 0.084 0.084 0.07 0.07
Accumulated Depreciation, Total -0.062 -0.058 -0.053 -0.049
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 0.001 0.001 0.001 0.001
Other Assets, Total 1.63 1.6 0.625 0.597
Total Current Liabilities 9.22 9.67 8.67 9.22
Accounts Payable 5.62 6.15 5.07 4.9
Payable/Accrued - - - -
Accrued Expenses 3.38 3.3 3.37 4.1
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 0.226 0.226 0.226 0.226
Total Liabilities 12.01 12.52 11.57 12.18
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 2.79 2.85 2.9 2.96
Total Equity 10.67 14.52 18.9 22.88
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.21 0.21 0.21 0.21
Additional Paid-In Capital 493.12 492.78 492.42 492.15
Retained Earnings (Accumulated Deficit) -482.63 -478.45 -473.71 -469.46
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -0.023 -0.03 -0.028 -0.027
Total Liabilities & Shareholders' Equity 22.68 27.04 30.47 35.06
Total Common Shares Outstanding 21 21 20.98 20.97
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TRAW Price Commentary

Write your thoughts about Traws Pharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Akila Chamika
Akila Chamika May 24, 2021 11:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
prediction from analysis is 17$ on 1st week of june. no sell ratings upto now
Kelvin Yeo
Kelvin Yeo May 24, 2021 10:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
cheating investor$$$
Neteli Neteli
Neteli Neteli May 21, 2021 10:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reverse Split - 1 for 15
Akila Chamika
Akila Chamika May 20, 2021 20:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what will be the end of today
Ralf Weber
Ralf Weber Mar 16, 2021 16:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Apparently RS is coming
Adriano Lucas
Adriano Lucas Mar 01, 2021 14:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good news coming this month check out hold strong you will be rewarded 🤑
Michael Price
Michael Price Feb 18, 2021 1:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next 6hourz? up or down? thoughts
Michael Price
Michael Price Feb 17, 2021 20:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy or sell this? what's the thoughts?
Neteli Neteli
Neteli Neteli Feb 17, 2021 15:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will this be the next Ocugen, Inc (OCGN)? I surely hope so...
Neteli Neteli
Neteli Neteli Feb 17, 2021 14:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Onconova Therapeutics, Inc. (NASDAQ:ONTX) SVP Abraham N. Oler bought 12,000 shares of the stock in a transaction that occurred on Tuesday, February 16th. --> something good is cooking?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email